Cargando…
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance
Acquired chemoresistance to proteasome inhibitors is a major obstacle in managing multiple myeloma but key regulators and underlying mechanisms still remain to be explored. We find that high level of HP1γ is associated with low acetylation modification in the bortezomib-resistant myeloma cells using...
Autores principales: | Li, Xin, Wang, Sheng, Xie, Ying, Jiang, Hongmei, Guo, Jing, Wang, Yixuan, Peng, Ziyi, Hu, Meilin, Wang, Mengqi, Wang, Jingya, Li, Qian, Wang, Yafei, Liu, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998874/ https://www.ncbi.nlm.nih.gov/pubmed/36894562 http://dx.doi.org/10.1038/s41467-023-37013-x |
Ejemplares similares
-
All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma
por: Peng, Ziyi, et al.
Publicado: (2023) -
Posttranslational modification of Aurora A‐NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma
por: Jiang, Hongmei, et al.
Publicado: (2022) -
Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation
por: Wang, Jingjing, et al.
Publicado: (2022) -
C-reactive protein impairs immune response of CD8(+) T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma
por: Jiang, Jinxing, et al.
Publicado: (2023) -
Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor in Multiple Myeloma
por: Wang, Yafei, et al.
Publicado: (2022)